It is currently Sat Jul 04, 2015 3:48 am

News News of Tysabri (Antegren or Natalizumab)

Site map of Tysabri (Antegren or Natalizumab) » Forum : Tysabri (Antegren or Natalizumab)

A board to discuss the newly-released drug Tysabri, (formerly known as Antegren) as a treatment for Multiple Sclerosis






Tysabri approved in EU

Just something i stumbled across this morning

The EU's CHMP has recommended approval of Elan and Biogen Idec's Tysabri (natalizumab), as a monotherapy for multiple sclerosis.

The product, which was launched in the US in late 2004 and voluntarily suspended two months later, has been given the go-ahead in the EU for use to delay the progression of disability and reduce the frequency of relapses in patients with high disease activity despite treatment with a ...
Read more : Tysabri approved in EU | Views : 1512 | Replies : 0


EU recommends restricted availability

Recommendations on Tysabri release restriction

28 April 2006 11:56

The European Medicines Agency (EMA) has recommended that the multiple sclerosis treatment drug, Tysabri, should be made available to patients on a restricted basis.

Tysabri was withdrawn from the market early in 2005 after some US patients who had been treated with the drug in combination with other medication developed the brain disease, PML.

The decision led to the collapse of Élan's share price.

Since then ...
Read more : EU recommends restricted availability | Views : 1420 | Replies : 1


Tysabri re-release

I lost my pipeline of informations regarding Tysabri, when my Dr. had by-pass surgery. I am looking ofr any information regarding its re-release. The news I got form my Dr.s RN was pretty discouraging.

Tracy Taggart
Read more : Tysabri re-release | Views : 1557 | Replies : 1


New Data on TYSABRI Demonstrate Significant Effects

6 April 2006

New Data on TYSABRI(R) Demonstrate Significant Effects on Health-Related Quality of Life Measures in Patients with Multiple Sclerosis

SAN DIEGO--(BUSINESS WIRE)--April 6, 2006--

Data presented at American Academy of Neurology Annual Meeting also Show Impact on Measures of Visual Function and Disability Progression

Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced today that in Phase III multiple sclerosis (MS) studies TYSABRI(R) (natalizumab) showed significant effects on pre-specified health-related quality ...
Read more : New Data on TYSABRI Demonstrate Significant Effects | Views : 1861 | Replies : 2


Conditions under which Tysabri will come back to market

I posted this in another thread just now, but figured it might need it's own thread. This is a March 27th update regarding the return of Tysabri:

http://www.nationalmssociety.org/tysabri_march8.asp

Excerpt:

"....Its key recommendations for approval include:

• Tysabri be made available only to patients who have enrolled along with their physicians in a mandatory registry program;

• Tysabri be made available only to patients diagnosed with relapsing MS;

• ...
Read more : Conditions under which Tysabri will come back to market | Views : 1994 | Replies : 3


Any SP MSer's take Tysabri?

Did anyone take Tysabri that was SP? And did it improve you any? I thought I had read about some that did.
Read more : Any SP MSer's take Tysabri? | Views : 2728 | Replies : 10


Experiences with Tysabri

This is a call for our members who currently are, or previously have taken, Tysabri for the treatment of MS to please share your experiences with the therapy at a new project that has sprung out of our work at This is MS, aptly titled "the Experience Project"

Born out of our experiences (no pun intended) here at This is MS, where a wonderful community has formed based (originally) on shared and common experience, the ...
Read more : Experiences with Tysabri | Views : 37119 | Replies : 62


 

Login  •  Register


Statistics

Total posts 226253 • Total topics 23796 • Total members 15098


Contact us | Terms of Service